| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0000045 | Autophagosome assembly | Increases phenotype | PMID:23880342; PMID:27492225; PMID:31862506; PMID:34952138; PMID:32693121; PMID:34952138 |
| GO:0000050 | Urea cycle | Affects phenotype | PMID:31639282 |
| GO:0000080 | Mitotic g1 phase | Increases phenotype | PMID:28035397; PMID:31614173 |
| GO:0000084 | Mitotic s phase | Decreases phenotype | PMID:28035397; PMID:28176351; PMID:31468104; PMID:31614173; PMID:31689473 |
| GO:0000085 | Mitotic g2 phase | Affects phenotype | PMID:28035397 |
| GO:0000086 | G2/m transition of mitotic cell cycle | Affects phenotype | PMID:28176351; PMID:31468104 |
| GO:0000104 | Succinate dehydrogenase activity | Decreases phenotype | PMID:20143725; PMID:37342552 |
| GO:0000278 | Mitotic cell cycle | Affects phenotype | PMID:28176351; PMID:31689473 |
| GO:0000422 | Autophagy of mitochondrion | Increases phenotype | PMID:25464205 |
| GO:0000423 | Mitophagy | Increases phenotype | PMID:32142837 |
| GO:0000723 | Telomere maintenance | Decreases phenotype | PMID:30722777 |
| GO:0000737 | Dna catabolic process, endonucleolytic | Increases phenotype | PMID:26089033; PMID:33396178 |
| GO:0001503 | Ossification | Decreases phenotype | PMID:32522577 |
| GO:0001510 | Rna methylation | Increases phenotype | PMID:34488496 |
| GO:0001525 | Angiogenesis | Affects phenotype | PMID:21425301 |
| GO:0001649 | Osteoblast differentiation | Decreases phenotype | PMID:36453845 |
| GO:0001662 | Behavioral fear response | Affects phenotype | PMID:32617577; PMID:37047547 |
| GO:0001776 | Leukocyte homeostasis | Affects phenotype | PMID:27181932 |
| GO:0001822 | Kidney development | Increases phenotype | PMID:30629257 |
| GO:0001836 | Release of cytochrome c from mitochondria | Increases phenotype | PMID:21787653; PMID:24144892; PMID:29115570; PMID:29891925; PMID:33031904 |
| GO:0001889 | Liver development | Affects phenotype | PMID:35770551 |
| GO:0001892 | Embryonic placenta development | Decreases phenotype | PMID:37941438 |
| GO:0001954 | Positive regulation of cell-matrix adhesion | Decreases phenotype | PMID:28829631 |
| GO:0002158 | Osteoclast proliferation | Increases phenotype | PMID:38896780 |
| GO:0002174 | Mammary stem cell proliferation | Decreases phenotype | PMID:29741670 |
| GO:0002246 | Wound healing involved in inflammatory response | Decreases phenotype | PMID:28666365 |
| GO:0002326 | B cell lineage commitment | Decreases phenotype | PMID:29939372 |
| GO:0002360 | T cell lineage commitment | Decreases phenotype | PMID:29939372 |
| GO:0002432 | Granuloma formation | Increases phenotype | PMID:38712533 |
| GO:0002523 | Leukocyte migration involved in inflammatory response | Increases phenotype | PMID:33359024; PMID:34816377; PMID:35934034; PMID:36718047; PMID:36718047; PMID:38712533; PMID:37270049; PMID:37342552; PMID:37357614; PMID:38712533; PMID:38945390; PMID:39396604 |
| GO:0003014 | Renal system process | Decreases phenotype | PMID:16263522; PMID:16581550; PMID:20836141; PMID:25012790; PMID:26513915; PMID:22027495; PMID:33036323; PMID:25536107 |
| GO:0003093 | Regulation of glomerular filtration | Affects phenotype | PMID:37949422 |
| GO:0003094 | Glomerular filtration | Decreases phenotype | PMID:16263522; PMID:19700501; PMID:26852280; PMID:33603096; PMID:37949422 |
| GO:0003104 | Positive regulation of glomerular filtration | Increases phenotype | PMID:31326826 |
| GO:0003105 | Negative regulation of glomerular filtration | Increases phenotype | PMID:22033168; PMID:25042034; PMID:25042034 |
| GO:0003700 | Dna-binding transcription factor activity | Affects phenotype | PMID:33642518 |
| GO:0003810 | Protein-glutamine gamma-glutamyltransferase activity | Increases phenotype | PMID:36718047 |
| GO:0003993 | Acid phosphatase activity | Increases phenotype | PMID:26089033 |
| GO:0004021 | L-alanine:2-oxoglutarate aminotransferase activity | Increases phenotype | PMID:34673407; PMID:38238535 |
| GO:0004035 | Alkaline phosphatase activity | Affects phenotype | PMID:26089033; PMID:31639282; PMID:31639282; PMID:36718047; PMID:32522577; PMID:33396178; PMID:34673407; PMID:38238535; PMID:36718047; PMID:37148155; PMID:38238535 |
| GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity | Affects phenotype | PMID:26089033; PMID:31390532; PMID:31390532; PMID:36718047; PMID:33359024; PMID:33642518; PMID:34673407; PMID:36718047; PMID:38238535 |
| GO:0004096 | Catalase activity | Decreases phenotype | PMID:32781062; PMID:34237468; PMID:35316447; PMID:38238535 |
| GO:0004111 | Creatine kinase activity | Increases phenotype | PMID:34237468; PMID:38712533 |
| GO:0004129 | Cytochrome-c oxidase activity | Decreases phenotype | PMID:33038468; PMID:37342552 |
| GO:0004197 | Cysteine-type endopeptidase activity | Increases phenotype | PMID:28413886; PMID:33497711 |
| GO:0004357 | Glutamate-cysteine ligase activity | Decreases phenotype | PMID:35384154 |
| GO:0004364 | Glutathione transferase activity | Affects phenotype | PMID:23543441; PMID:24952260; PMID:26089033; PMID:26363317; PMID:30359721; PMID:31639282; PMID:34237468; PMID:39270966 |
| GO:0004448 | Isocitrate dehydrogenase [nad(p)+] activity | Decreases phenotype | PMID:37342552 |
| GO:0004457 | Lactate dehydrogenase activity | Increases phenotype | PMID:20143725; PMID:26089033; PMID:30029485; PMID:30717178; PMID:31639282; PMID:38238535 |
| GO:0004591 | Oxoglutarate dehydrogenase (succinyl-transferring) activity | Decreases phenotype | PMID:37342552 |
| GO:0004602 | Glutathione peroxidase activity | Affects phenotype | PMID:15055539; PMID:32347499; PMID:19778222; PMID:21787725; PMID:22995158; PMID:23543441; PMID:22995158; PMID:23543441; PMID:23577223; PMID:26089033; PMID:30717178; PMID:31390532; PMID:31639282; PMID:31876186; PMID:32347499; PMID:33559965; PMID:34237468; PMID:34767868; PMID:34952138; PMID:35316447; PMID:35384154; PMID:35489423; PMID:37270049; PMID:39842396; PMID:37342552; PMID:37342552; PMID:37949422; PMID:37949422; PMID:38238535; PMID:38945390; PMID:39842396 |
| GO:0004623 | Phospholipase a2 activity | Increases phenotype | PMID:25808797 |
| GO:0004705 | Jun kinase activity | Increases phenotype | PMID:21425301; PMID:25069788 |
| GO:0004707 | Map kinase activity | Increases phenotype | PMID:21425301; PMID:25069788 |
| GO:0004784 | Superoxide dismutase activity | Increases phenotype | PMID:15055539; PMID:32347499; PMID:19778222; PMID:22995158; PMID:23543441; PMID:23577223; PMID:26051590; PMID:26089033; PMID:26363317; PMID:30029485; PMID:30717178; PMID:31639282; PMID:31639282; PMID:36718047; PMID:31876186; PMID:32347499; PMID:32735850; PMID:32781062; PMID:32781062; PMID:36356678; PMID:33404196; PMID:33559965; PMID:34237468; PMID:34510229; PMID:34952138; PMID:35316447; PMID:35489423; PMID:36356678; PMID:36718047; PMID:36918407; PMID:37022104; PMID:37342552; PMID:37342552; PMID:37949422; PMID:39197519; PMID:37949422; PMID:38238535; PMID:38289529; PMID:39197519; PMID:39725363; PMID:39842396 |
| GO:0004791 | Thioredoxin-disulfide reductase activity | Decreases phenotype | PMID:29975440 |
| GO:0004833 | Tryptophan 2,3-dioxygenase activity | Increases phenotype | PMID:35489423 |
| GO:0005262 | Calcium channel activity | Affects phenotype | PMID:29993192 |
| GO:0005272 | Sodium channel activity | Affects phenotype | PMID:29993192 |
| GO:0005388 | P-type calcium transporter activity | Decreases phenotype | PMID:26089033 |
| GO:0005391 | P-type sodium:potassium-exchanging transporter activity | Decreases phenotype | PMID:26089033 |
| GO:0005506 | Iron ion binding | Decreases phenotype | PMID:32645461 |
| GO:0005776 | Autophagosome | Increases phenotype | PMID:34673407; PMID:34952138; PMID:37270049 |
| GO:0005884 | Actin filament | Increases phenotype | PMID:30614199 |
| GO:0005977 | Glycogen metabolic process | Affects phenotype | PMID:37270049; PMID:38945390 |
| GO:0005988 | Lactose metabolic process | Affects phenotype | PMID:38945390 |
| GO:0006006 | Glucose metabolic process | Affects phenotype | PMID:25043455; PMID:36509832; PMID:37270049; PMID:38945390 |
| GO:0006089 | Lactate metabolic process | Affects phenotype | PMID:33038468; PMID:33404196; PMID:34481905 |
| GO:0006090 | Pyruvate metabolic process | Affects phenotype | PMID:33404196 |
| GO:0006096 | Glycolytic process | Affects phenotype | PMID:34481905 |
| GO:0006099 | Tricarboxylic acid cycle | Affects phenotype | PMID:37342552 |
| GO:0006119 | Oxidative phosphorylation | Increases phenotype | PMID:34481905 |
| GO:0006163 | Purine nucleotide metabolic process | Affects phenotype | PMID:35100813; PMID:39842396 |
| GO:0006182 | Cgmp biosynthetic process | Decreases phenotype | PMID:23703608 |
| GO:0006264 | Mitochondrial dna replication | Increases phenotype | PMID:25388156 |
| GO:0006277 | Dna amplification | Increases phenotype | PMID:2455903 |
| GO:0006281 | Dna repair | Affects phenotype | PMID:31769258 |
| GO:0006304 | Dna modification | Increases phenotype | PMID:35316447; PMID:3683394; PMID:38563870 |
| GO:0006306 | Dna methylation | Decreases phenotype | PMID:20137407; PMID:22382075; PMID:29529597; PMID:39119833 |
| GO:0006308 | Dna catabolic process | Increases phenotype | PMID:22677345; PMID:35384154 |
| GO:0006309 | Apoptotic dna fragmentation | Increases phenotype | PMID:10970901; PMID:15954739; PMID:25388156; PMID:29111403 |
| GO:0006349 | Regulation of gene expression by genomic imprinting | Affects phenotype | PMID:31082282 |
| GO:0006490 | Oligosaccharide-lipid intermediate biosynthetic process | Affects phenotype | PMID:3667605 |
| GO:0006497 | Protein lipidation | Increases phenotype | PMID:32142837; PMID:32693121; PMID:34481905; PMID:34481905; PMID:36336208; PMID:34695510; PMID:36336208; PMID:37148155 |
| GO:0006520 | Amino acid metabolic process | Affects phenotype | PMID:27401458; PMID:35301059 |
| GO:0006522 | Alanine metabolic process | Affects phenotype | PMID:32917723 |
| GO:0006534 | Cysteine metabolic process | Affects phenotype | PMID:32917723 |
| GO:0006544 | Glycine metabolic process | Affects phenotype | PMID:32917723 |
| GO:0006606 | Protein import into nucleus | Affects phenotype | PMID:37949422 |
| GO:0006629 | Lipid metabolic process | Affects phenotype | PMID:34237468; PMID:38712533; PMID:39842396 |
| GO:0006631 | Fatty acid metabolic process | Affects phenotype | PMID:28433638; PMID:35301059 |
| GO:0006641 | Triglyceride metabolic process | Affects phenotype | PMID:34516972; PMID:36718047; PMID:38945390 |
| GO:0006644 | Phospholipid metabolic process | Affects phenotype | PMID:35301059 |
| GO:0006693 | Prostaglandin metabolic process | Affects phenotype | PMID:35316447 |
| GO:0006695 | Cholesterol biosynthetic process | Increases phenotype | PMID:23543441; PMID:25240712 |
| GO:0006703 | Estrogen biosynthetic process | Affects phenotype | PMID:31793751 |
| GO:0006739 | Nadp metabolic process | Affects phenotype | PMID:38945390 |
| GO:0006749 | Glutathione metabolic process | Affects phenotype | PMID:24967604; PMID:26089033; PMID:26363317; PMID:30717178; PMID:30804470; PMID:31876186; PMID:32735850; PMID:33497711; PMID:33559965; PMID:34767868; PMID:35316447; PMID:35384154; PMID:36718047; PMID:36918407; PMID:37270049; PMID:37676925; PMID:37949422; PMID:39025289 |
| GO:0006750 | Glutathione biosynthetic process | Increases phenotype | PMID:18573614; PMID:21787725; PMID:22995158; PMID:23543441; PMID:22467032; PMID:22995158; PMID:23543441; PMID:24952260; PMID:25388156; PMID:30359721; PMID:31639282 |
| GO:0006754 | Atp biosynthetic process | Decreases phenotype | PMID:25388156; PMID:27289041 |
| GO:0006772 | Thiamine metabolic process | Affects phenotype | PMID:39842396 |
| GO:0006778 | Porphyrin-containing compound metabolic process | Affects phenotype | PMID:30529385; PMID:31491373 |
| GO:0006811 | Monoatomic ion transport | Decreases phenotype | PMID:8884763 |
| GO:0006812 | Monoatomic cation transport | Affects phenotype | PMID:32080757 |
| GO:0006813 | Potassium ion transport | Affects phenotype | PMID:33038468 |
| GO:0006825 | Copper ion transport | Affects phenotype | PMID:32879253 |
| GO:0006874 | Cellular calcium ion homeostasis | Affects phenotype | PMID:23902534; PMID:26089033; PMID:28176351; PMID:32080757; PMID:32599263; PMID:33559965; PMID:33617915; PMID:34516972; PMID:37300854 |
| GO:0006875 | Cellular metal ion homeostasis | Affects phenotype | PMID:35212737 |
| GO:0006876 | Cellular cadmium ion homeostasis | Increases phenotype | PMID:28464991; PMID:38195004 |
| GO:0006879 | Cellular iron ion homeostasis | Affects phenotype | PMID:26089033; PMID:39025289 |
| GO:0006914 | Autophagy | Affects phenotype | PMID:25955216; PMID:27492225; PMID:27658547; PMID:32693121; PMID:34673407; PMID:36336208 |
| GO:0006915 | Apoptotic process | Increases phenotype | PMID:15954739; PMID:17897638; PMID:20137407; PMID:21787653; PMID:22677345; PMID:23315796; PMID:23339468; PMID:23577223; PMID:23650964; PMID:23741317; PMID:23741317; PMID:29891925; PMID:23880342; PMID:24144892; PMID:24212999; PMID:25227780; PMID:25388156; PMID:39197519; PMID:25643798; PMID:27658547; PMID:28035397; PMID:28507149; PMID:28949029; PMID:29111403; PMID:29115570; PMID:29891925; PMID:29993192; PMID:30029485; PMID:30717178; PMID:30796935; PMID:30796935; PMID:32199951; PMID:30804470; PMID:31614173; PMID:32058163; PMID:32599263; PMID:32697411; PMID:33031904; PMID:33359024; PMID:33398418; PMID:33559965; PMID:33652105; PMID:33857584; PMID:34558789; PMID:34558789; PMID:34767868; PMID:34767868; PMID:34791780; PMID:34998821; PMID:35384129; PMID:35870590; PMID:35955783; PMID:36718047; PMID:36718047; PMID:38712533; PMID:37300854; PMID:38001299; PMID:39119833; PMID:39197519; PMID:39725363; PMID:39892737 |
| GO:0006919 | Activation of cysteine-type endopeptidase activity involved in apoptotic process | Increases phenotype | PMID:29982767 |
| GO:0006935 | Chemotaxis | Increases phenotype | PMID:32080757 |
| GO:0006950 | Response to stress | Affects phenotype | PMID:3667605 |
| GO:0006954 | Inflammatory response | Increases phenotype | PMID:23636881; PMID:31390532; PMID:37022104; PMID:38759447 |
| GO:0006974 | Cellular response to dna damage stimulus | Increases phenotype | PMID:23577223; PMID:33031904 |
| GO:0006979 | Response to oxidative stress | Increases phenotype | PMID:12927907; PMID:20399841; PMID:23578882; PMID:30529889 |
| GO:0006997 | Nucleus organization | Decreases phenotype | PMID:26165643; PMID:28949029; PMID:34952138 |
| GO:0007005 | Mitochondrion organization | Decreases phenotype | PMID:25159133; PMID:30614199; PMID:33559965; PMID:33617915; PMID:34481905; PMID:34673407; PMID:34952138; PMID:37022104; PMID:39025289 |
| GO:0007006 | Mitochondrial membrane organization | Affects phenotype | PMID:33038468 |
| GO:0007009 | Plasma membrane organization | Decreases phenotype | PMID:30614199 |
| GO:0007033 | Vacuole organization | Increases phenotype | PMID:27658547; PMID:33559965; PMID:33652105; PMID:34952138; PMID:35489423; PMID:37506864; PMID:38712533 |
| GO:0007042 | Lysosomal lumen acidification | Increases phenotype | PMID:22677345; PMID:31862506 |
| GO:0007049 | Cell cycle | Affects phenotype | PMID:23941782 |
| GO:0007056 | Spindle assembly involved in female meiosis | Decreases phenotype | PMID:29684212 |
| GO:0007183 | Smad protein complex assembly | Decreases phenotype | PMID:36453845 |
| GO:0007204 | Positive regulation of cytosolic calcium ion concentration | Increases phenotype | PMID:26165643 |
| GO:0007267 | Cell-cell signaling | Decreases phenotype | PMID:28176351 |
| GO:0007283 | Spermatogenesis | Decreases phenotype | PMID:20137407; PMID:29527696; PMID:31491373; PMID:31654709; PMID:32199951; PMID:35870590; PMID:32347499; PMID:32781062; PMID:32976933; PMID:33372294; PMID:34791780; PMID:35236366; PMID:37506864 |
| GO:0007284 | Spermatogonial cell division | Affects phenotype | PMID:37506864 |
| GO:0007420 | Brain development | Decreases phenotype | PMID:20829427; PMID:35770551 |
| GO:0007601 | Visual perception | Decreases phenotype | PMID:31666078 |
| GO:0007610 | Behavior | Affects phenotype | PMID:31491373 |
| GO:0007611 | Learning or memory | Decreases phenotype | PMID:23379984; PMID:29029324; PMID:38579196 |
| GO:0007613 | Memory | Decreases phenotype | PMID:29170048; PMID:30090589; PMID:31626305; PMID:32617577; PMID:35489423; PMID:38595292 |
| GO:0007625 | Grooming behavior | Increases phenotype | PMID:37047547 |
| GO:0007631 | Feeding behavior | Decreases phenotype | PMID:31390532; PMID:34237468; PMID:34237468; PMID:36278208; PMID:37676925 |
| GO:0008121 | Ubiquinol-cytochrome-c reductase activity | Decreases phenotype | PMID:33038468; PMID:37342552 |
| GO:0008137 | Nadh dehydrogenase (ubiquinone) activity | Decreases phenotype | PMID:33038468; PMID:37342552 |
| GO:0008152 | Metabolic process | Affects phenotype | PMID:29656123; PMID:35934034 |
| GO:0008177 | Succinate dehydrogenase (ubiquinone) activity | Decreases phenotype | PMID:33038468; PMID:37342552 |
| GO:0008203 | Cholesterol metabolic process | Affects phenotype | PMID:34998821; PMID:36718047; PMID:37236586; PMID:38945390 |
| GO:0008206 | Bile acid metabolic process | Affects phenotype | PMID:30090589; PMID:31491373; PMID:35934034; PMID:38945390 |
| GO:0008210 | Estrogen metabolic process | Affects phenotype | PMID:30478740; PMID:35236366 |
| GO:0008217 | Regulation of blood pressure | Affects phenotype | PMID:30477816 |
| GO:0008219 | Cell death | Increases phenotype | PMID:23578882; PMID:26537420; PMID:27005776; PMID:27658547; PMID:27871888; PMID:30614199; PMID:32735850; PMID:33497711 |
| GO:0008283 | Cell population proliferation | Increases phenotype | PMID:11749125; PMID:21787653; PMID:22634143; PMID:22677345; PMID:23548128; PMID:23577223; PMID:23880342; PMID:25343777; PMID:25388156; PMID:25643798; PMID:25955216; PMID:26006730; PMID:26006730; PMID:8207012; PMID:26537420; PMID:27071802; PMID:27658547; PMID:28315714; PMID:29111403; PMID:31614173; PMID:31689473; PMID:32781062; PMID:33857584; PMID:34816377; PMID:34952138; PMID:35934034; PMID:36602393; PMID:38563870; PMID:38712533; PMID:38944328 |
| GO:0008284 | Positive regulation of cell population proliferation | Increases phenotype | PMID:39191366 |
| GO:0008285 | Negative regulation of cell population proliferation | Increases phenotype | PMID:31271426; PMID:35134237 |
| GO:0008355 | Olfactory learning | Decreases phenotype | PMID:29029324; PMID:33039505 |
| GO:0008361 | Regulation of cell size | Affects phenotype | PMID:34875320 |
| GO:0008584 | Male gonad development | Decreases phenotype | PMID:32199951 |
| GO:0008652 | Amino acid biosynthetic process | Affects phenotype | PMID:28433638 |
| GO:0008653 | Lipopolysaccharide metabolic process | Affects phenotype | PMID:35934034 |
| GO:0008654 | Phospholipid biosynthetic process | Increases phenotype | PMID:23543441; PMID:25240712 |
| GO:0009060 | Aerobic respiration | Decreases phenotype | PMID:31756223 |
| GO:0009116 | Nucleoside metabolic process | Affects phenotype | PMID:35301059 |
| GO:0009117 | Nucleotide metabolic process | Affects phenotype | PMID:35301059 |
| GO:0009308 | Amine metabolic process | Affects phenotype | PMID:39842396 |
| GO:0009435 | Nad biosynthetic process | Decreases phenotype | PMID:27289041 |
| GO:0009749 | Response to glucose | Decreases phenotype | PMID:30629257; PMID:33259630 |
| GO:0009790 | Embryo development | Decreases phenotype | PMID:37941438 |
| GO:0009812 | Flavonoid metabolic process | Affects phenotype | PMID:39842396 |
| GO:0010189 | Vitamin e biosynthetic process | Decreases phenotype | PMID:23543441 |
| GO:0010288 | Response to lead ion | Affects phenotype | PMID:19938001 |
| GO:0010424 | Dna methylation on cytosine within a cg sequence | Affects phenotype | PMID:23644563; PMID:24169490; PMID:29373860; PMID:32484362 |
| GO:0010467 | Gene expression | Affects phenotype | PMID:24936443; PMID:28899425 |
| GO:0010498 | Proteasomal protein catabolic process | Decreases phenotype | PMID:22995398 |
| GO:0010508 | Positive regulation of autophagy | Increases phenotype | PMID:30985881 |
| GO:0010659 | Cardiac muscle cell apoptotic process | Increases phenotype | PMID:29982767 |
| GO:0010729 | Positive regulation of hydrogen peroxide biosynthetic process | Increases phenotype | PMID:37244046 |
| GO:0010918 | Positive regulation of mitochondrial membrane potential | Decreases phenotype | PMID:25981801 |
| GO:0010940 | Positive regulation of necrotic cell death | Increases phenotype | PMID:24824807; PMID:28587817 |
| GO:0010942 | Positive regulation of cell death | Increases phenotype | PMID:25159133; PMID:25981801; PMID:26165643; PMID:26259607 |
| GO:0014002 | Astrocyte development | Decreases phenotype | PMID:20829427 |
| GO:0014047 | Glutamate secretion | Decreases phenotype | PMID:30614199 |
| GO:0015267 | Channel activity | Increases phenotype | PMID:20133428 |
| GO:0015444 | P-type magnesium transporter activity | Decreases phenotype | PMID:26089033 |
| GO:0015691 | Cadmium ion transport | Increases phenotype | PMID:23238610 |
| GO:0015727 | Lactate transport | Increases phenotype | PMID:39427783 |
| GO:0016042 | Lipid catabolic process | Increases phenotype | PMID:22995158; PMID:22995158; PMID:23543441; PMID:23543441; PMID:23577223; PMID:31319114; PMID:31390532; PMID:31639282; PMID:32735850; PMID:33398418; PMID:33404196; PMID:33559965; PMID:34695510; PMID:35384154; PMID:35489423 |
| GO:0016049 | Cell growth | Affects phenotype | PMID:28507149 |
| GO:0016160 | Amylase activity | Decreases phenotype | PMID:38712533 |
| GO:0016477 | Cell migration | Affects phenotype | PMID:22884995; PMID:28315714; PMID:31437537; PMID:33559965; PMID:34488496; PMID:34687772 |
| GO:0016567 | Protein ubiquitination | Increases phenotype | PMID:29415948 |
| GO:0016615 | Malate dehydrogenase activity | Decreases phenotype | PMID:37342552 |
| GO:0016887 | Atp hydrolysis activity | Affects phenotype | PMID:34952138 |
| GO:0017015 | Regulation of transforming growth factor beta receptor signaling pathway | Affects phenotype | PMID:29408318 |
| GO:0018158 | Protein oxidation | Increases phenotype | PMID:22995158; PMID:26089033; PMID:35384154 |
| GO:0018171 | Peptidyl-cysteine oxidation | Increases phenotype | PMID:24077948 |
| GO:0018345 | Protein palmitoylation | Increases phenotype | PMID:38195004 |
| GO:0018904 | Ether metabolic process | Affects phenotype | PMID:39842396 |
| GO:0019216 | Regulation of lipid metabolic process | Affects phenotype | PMID:30529385; PMID:38382403 |
| GO:0019432 | Triglyceride biosynthetic process | Increases phenotype | PMID:23543441; PMID:25240712 |
| GO:0019538 | Protein metabolic process | Affects phenotype | PMID:31491373 |
| GO:0019627 | Urea metabolic process | Affects phenotype | PMID:37342552; PMID:37949422; PMID:38945390; PMID:39842396 |
| GO:0019695 | Choline metabolic process | Affects phenotype | PMID:27401458 |
| GO:0019722 | Calcium-mediated signaling | Affects phenotype | PMID:38579196 |
| GO:0019752 | Carboxylic acid metabolic process | Affects phenotype | PMID:32917723; PMID:39842396 |
| GO:0019852 | L-ascorbic acid metabolic process | Affects phenotype | PMID:26089033; PMID:34791780 |
| GO:0019853 | L-ascorbic acid biosynthetic process | Decreases phenotype | PMID:23543441 |
| GO:0021953 | Central nervous system neuron differentiation | Decreases phenotype | PMID:31271426 |
| GO:0022008 | Neurogenesis | Decreases phenotype | PMID:31271426; PMID:31626305; PMID:32617577 |
| GO:0030001 | Metal ion transport | Decreases phenotype | PMID:28721440 |
| GO:0030097 | Hemopoiesis | Decreases phenotype | PMID:38945390; PMID:39461408 |
| GO:0030182 | Neuron differentiation | Affects phenotype | PMID:31626305; PMID:33387572 |
| GO:0030199 | Collagen fibril organization | Increases phenotype | PMID:34875320; PMID:37022104; PMID:37270049; PMID:38712533 |
| GO:0030220 | Platelet formation | Decreases phenotype | PMID:31991237 |
| GO:0030223 | Neutrophil differentiation | Decreases phenotype | PMID:29939372 |
| GO:0030224 | Monocyte differentiation | Decreases phenotype | PMID:29939372 |
| GO:0030263 | Apoptotic chromosome condensation | Increases phenotype | PMID:29170048; PMID:32735850; PMID:33559965; PMID:34673407; PMID:35100813; PMID:35489423; PMID:38595292 |
| GO:0030282 | Bone mineralization | Decreases phenotype | PMID:22151692 |
| GO:0030308 | Negative regulation of cell growth | Increases phenotype | PMID:27687512 |
| GO:0030316 | Osteoclast differentiation | Increases phenotype | PMID:23954550; PMID:31793751; PMID:32522522 |
| GO:0031175 | Neuron projection development | Decreases phenotype | PMID:36114956 |
| GO:0031343 | Positive regulation of cell killing | Affects phenotype | PMID:26165643 |
| GO:0031589 | Cell-substrate adhesion | Decreases phenotype | PMID:33422613; PMID:38563870 |
| GO:0031966 | Mitochondrial membrane | Affects phenotype | PMID:33038468 |
| GO:0031987 | Locomotion involved in locomotory behavior | Decreases phenotype | PMID:31166132; PMID:32735850; PMID:35489423; PMID:36918407 |
| GO:0032060 | Bleb assembly | Increases phenotype | PMID:37357614 |
| GO:0032125 | Micronucleus organization | Increases phenotype | PMID:31639282 |
| GO:0032471 | Negative regulation of endoplasmic reticulum calcium ion concentration | Increases phenotype | PMID:37300854 |
| GO:0032680 | Regulation of tumor necrosis factor production | Affects phenotype | PMID:31652851 |
| GO:0032760 | Positive regulation of tumor necrosis factor production | Increases phenotype | PMID:29028684; PMID:31652851 |
| GO:0032868 | Response to insulin | Affects phenotype | PMID:33259630 |
| GO:0032941 | Secretion by tissue | Increases phenotype | PMID:38759447 |
| GO:0032964 | Collagen biosynthetic process | Increases phenotype | PMID:30912652 |
| GO:0033023 | Mast cell homeostasis | Affects phenotype | PMID:38712533 |
| GO:0033554 | Cellular response to stress | Affects phenotype | PMID:3093479 |
| GO:0033754 | Indoleamine 2,3-dioxygenase activity | Increases phenotype | PMID:35489423 |
| GO:0034101 | Erythrocyte homeostasis | Affects phenotype | PMID:27181932 |
| GO:0034440 | Lipid oxidation | Increases phenotype | PMID:19778222; PMID:26089033; PMID:29408764; PMID:30717178; PMID:31876186; PMID:33372294; PMID:34237468; PMID:35316447; PMID:36356678; PMID:36718047; PMID:36868496; PMID:36918407; PMID:37342552; PMID:37676925; PMID:37949422; PMID:38289529; PMID:38595292; PMID:38945390; PMID:39025289; PMID:39842396 |
| GO:0034504 | Protein localization to nucleus | Increases phenotype | PMID:24077948 |
| GO:0034599 | Cellular response to oxidative stress | Increases phenotype | PMID:22713677 |
| GO:0034720 | Histone h3-k4 demethylation | Decreases phenotype | PMID:25673502 |
| GO:0034757 | Negative regulation of iron ion transport | Affects phenotype | PMID:32879253 |
| GO:0035176 | Social behavior | Decreases phenotype | PMID:37047547 |
| GO:0035640 | Exploration behavior | Affects phenotype | PMID:35489423 |
| GO:0035641 | Locomotory exploration behavior | Decreases phenotype | PMID:37047547 |
| GO:0035752 | Lysosomal lumen ph elevation | Increases phenotype | PMID:34516972 |
| GO:0035855 | Megakaryocyte development | Decreases phenotype | PMID:35134237 |
| GO:0035934 | Corticosterone secretion | Increases phenotype | PMID:35384129 |
| GO:0035936 | Testosterone secretion | Decreases phenotype | PMID:30717178; PMID:31654709; PMID:32199951 |
| GO:0036123 | Histone h3-k9 dimethylation | Increases phenotype | PMID:25673502 |
| GO:0036211 | Protein modification process | Increases phenotype | PMID:21787725; PMID:34875320 |
| GO:0036499 | Perk-mediated unfolded protein response | Increases phenotype | PMID:29373603 |
| GO:0040007 | Growth | Decreases phenotype | PMID:36918407 |
| GO:0042110 | T cell activation | Affects phenotype | PMID:39396604 |
| GO:0042116 | Macrophage activation | Increases phenotype | PMID:32917723; PMID:33359024 |
| GO:0042158 | Lipoprotein biosynthetic process | Affects phenotype | PMID:25240712 |
| GO:0042214 | Terpene metabolic process | Affects phenotype | PMID:39842396 |
| GO:0042278 | Purine nucleoside metabolic process | Affects phenotype | PMID:39842396 |
| GO:0042304 | Regulation of fatty acid biosynthetic process | Affects phenotype | PMID:26187450 |
| GO:0042310 | Vasoconstriction | Increases phenotype | PMID:11736687; PMID:23973752 |
| GO:0042360 | Vitamin e metabolic process | Affects phenotype | PMID:26089033 |
| GO:0042403 | Thyroid hormone metabolic process | Affects phenotype | PMID:30090589; PMID:38712533; PMID:38797200 |
| GO:0042551 | Neuron maturation | Decreases phenotype | PMID:36114956 |
| GO:0042554 | Superoxide anion generation | Affects phenotype | PMID:34952138 |
| GO:0042573 | Retinoic acid metabolic process | Affects phenotype | PMID:37506864 |
| GO:0042593 | Glucose homeostasis | Affects phenotype | PMID:27312901; PMID:30629257; PMID:33259630 |
| GO:0042696 | Menarche | Affects phenotype | PMID:36729392 |
| GO:0042701 | Progesterone secretion | Affects phenotype | PMID:31654709 |
| GO:0042743 | Hydrogen peroxide metabolic process | Increases phenotype | PMID:26089033; PMID:31876186 |
| GO:0042756 | Drinking behavior | Affects phenotype | PMID:34237468; PMID:34237468; PMID:36278208; PMID:34998821; PMID:37676925 |
| GO:0042775 | Mitochondrial atp synthesis coupled electron transport | Decreases phenotype | PMID:31756223 |
| GO:0043029 | T cell homeostasis | Affects phenotype | PMID:39396604 |
| GO:0043046 | Dna methylation involved in gamete generation | Affects phenotype | PMID:33483743 |
| GO:0043065 | Positive regulation of apoptotic process | Increases phenotype | PMID:20829427; PMID:27687512; PMID:28587817; PMID:30985881; PMID:37244046 |
| GO:0043525 | Positive regulation of neuron apoptotic process | Increases phenotype | PMID:24824807 |
| GO:0043983 | Histone h4-k12 acetylation | Affects phenotype | PMID:29684212 |
| GO:0044062 | Regulation of excretion | Increases phenotype | PMID:23806787 |
| GO:0044237 | Cellular metabolic process | Increases phenotype | PMID:23968883; PMID:26363317; PMID:28035397; PMID:28176351; PMID:28949029; PMID:29115570; PMID:29298499; PMID:29957541; PMID:29993192; PMID:30029485; PMID:30478740; PMID:30614199; PMID:30717178; PMID:30796935; PMID:30796935; PMID:32199951; PMID:30804470; PMID:31154059; PMID:31166132; PMID:31319114; PMID:31468104; PMID:31614173; PMID:31953414; PMID:32058163; PMID:32142837; PMID:32522522; PMID:33031904; PMID:33188856; PMID:33387572; PMID:33396178; PMID:33559965; PMID:33617915; PMID:33774064; PMID:37300869; PMID:33857584; PMID:33857584; PMID:35100813; PMID:34510229; PMID:34558789; PMID:34558789; PMID:34767868; PMID:36527706; PMID:34695510; PMID:34767868; PMID:34773240; PMID:34822840; PMID:34952138; PMID:35100813; PMID:35301059; PMID:35384129; PMID:35384129; PMID:35908931; PMID:36336208; PMID:36527706; PMID:36602393; PMID:37236586; PMID:37300854; PMID:37300869; PMID:37357614; PMID:37506864; PMID:38001299; PMID:38156290; PMID:38289529; PMID:38944328; PMID:39025289; PMID:39725363; PMID:39778647 |
| GO:0044242 | Cellular lipid catabolic process | Increases phenotype | PMID:21787725 |
| GO:0044308 | Axonal spine | Decreases phenotype | PMID:30614199 |
| GO:0044319 | Wound healing, spreading of cells | Increases phenotype | PMID:31319114; PMID:32080757; PMID:34481905; PMID:34481905; PMID:36336208; PMID:36336208 |
| GO:0044754 | Autolysosome | Increases phenotype | PMID:34481905 |
| GO:0045023 | G0 to g1 transition | Affects phenotype | PMID:28176351; PMID:31689473 |
| GO:0045165 | Cell fate commitment | Decreases phenotype | PMID:36114956 |
| GO:0045214 | Sarcomere organization | Decreases phenotype | PMID:29993192 |
| GO:0045302 | Choloylglycine hydrolase activity | Decreases phenotype | PMID:35934034 |
| GO:0045329 | Carnitine biosynthetic process | Increases phenotype | PMID:30529385 |
| GO:0045333 | Cellular respiration | Decreases phenotype | PMID:33038468 |
| GO:0045444 | Fat cell differentiation | Increases phenotype | PMID:31793751; PMID:36453845 |
| GO:0045453 | Bone resorption | Increases phenotype | PMID:18560534; PMID:22151692; PMID:23954550; PMID:31793751 |
| GO:0045454 | Cell redox homeostasis | Decreases phenotype | PMID:24496640; PMID:37244046 |
| GO:0045653 | Negative regulation of megakaryocyte differentiation | Increases phenotype | PMID:35134237 |
| GO:0045792 | Negative regulation of cell size | Increases phenotype | PMID:38712533 |
| GO:0045795 | Positive regulation of cell volume | Increases phenotype | PMID:37357614 |
| GO:0045930 | Negative regulation of mitotic cell cycle | Affects phenotype | PMID:27071802; PMID:31614173 |
| GO:0045992 | Negative regulation of embryonic development | Increases phenotype | PMID:29684212 |
| GO:0046034 | Atp metabolic process | Affects phenotype | PMID:33038468; PMID:33404196; PMID:33497711; PMID:34952138; PMID:36527706; PMID:39025289 |
| GO:0046083 | Adenine metabolic process | Affects phenotype | PMID:35301059 |
| GO:0046209 | Nitric oxide metabolic process | Affects phenotype | PMID:26089033; PMID:31639282; PMID:37676925 |
| GO:0046323 | Glucose import | Affects phenotype | PMID:34481905 |
| GO:0046325 | Negative regulation of glucose import | Increases phenotype | PMID:39191366 |
| GO:0046330 | Positive regulation of jnk cascade | Increases phenotype | PMID:24824807; PMID:26187450 |
| GO:0046415 | Urate metabolic process | Affects phenotype | PMID:39842396 |
| GO:0046449 | Creatinine metabolic process | Affects phenotype | PMID:31639282; PMID:31639282; PMID:35384154; PMID:35384154; PMID:37270049; PMID:37342552; PMID:37357614; PMID:37949422; PMID:37949422; PMID:39025289; PMID:39197519; PMID:38945390; PMID:39197519; PMID:39842396 |
| GO:0046466 | Membrane lipid catabolic process | Increases phenotype | PMID:12927907; PMID:32976933; PMID:37244046 |
| GO:0046686 | Response to cadmium ion | Increases phenotype | PMID:37941438 |
| GO:0046697 | Decidualization | Affects phenotype | PMID:39892737 |
| GO:0046722 | Lactic acid secretion | Increases phenotype | PMID:32917723 |
| GO:0046849 | Bone remodeling | Affects phenotype | PMID:30848671 |
| GO:0048102 | Autophagic cell death | Increases phenotype | PMID:27492225 |
| GO:0048137 | Spermatocyte division | Affects phenotype | PMID:37506864 |
| GO:0048312 | Intracellular distribution of mitochondria | Decreases phenotype | PMID:29684212 |
| GO:0048589 | Developmental growth | Decreases phenotype | PMID:35646058 |
| GO:0048708 | Astrocyte differentiation | Increases phenotype | PMID:33387572 |
| GO:0048871 | Multicellular organismal homeostasis | Decreases phenotype | PMID:31491373 |
| GO:0048874 | Host-mediated regulation of intestinal microbiota composition | Affects phenotype | PMID:35037767; PMID:35934034 |
| GO:0050679 | Positive regulation of epithelial cell proliferation | Increases phenotype | PMID:22884995 |
| GO:0050729 | Positive regulation of inflammatory response | Increases phenotype | PMID:25288670; PMID:30529385; PMID:31463135; PMID:37403423 |
| GO:0050768 | Negative regulation of neurogenesis | Increases phenotype | PMID:33039505 |
| GO:0050801 | Monoatomic ion homeostasis | Affects phenotype | PMID:30090589 |
| GO:0050890 | Cognition | Decreases phenotype | PMID:23379984; PMID:31666078; PMID:25288670; PMID:31626305; PMID:32735850 |
| GO:0050892 | Intestinal absorption | Affects phenotype | PMID:32879253 |
| GO:0051238 | Sequestering of metal ion | Increases phenotype | PMID:27984135 |
| GO:0051280 | Negative regulation of release of sequestered calcium ion into cytosol | Increases phenotype | PMID:28666365 |
| GO:0051567 | Histone h3-k9 methylation | Affects phenotype | PMID:29684212 |
| GO:0051646 | Mitochondrion localization | Affects phenotype | PMID:33617915 |
| GO:0051881 | Regulation of mitochondrial membrane potential | Affects phenotype | PMID:10970901; PMID:21787653; PMID:23741317; PMID:24144892; PMID:25159133; PMID:25464205; PMID:25643798; PMID:25808797; PMID:29891925; PMID:32142837; PMID:33038468; PMID:33559965; PMID:33617915; PMID:34558789; PMID:34558789; PMID:36527706; PMID:34952138; PMID:36527706; PMID:37342552; PMID:39025289 |
| GO:0051882 | Mitochondrial depolarization | Increases phenotype | PMID:23315796; PMID:29115570; PMID:33497711; PMID:34481905; PMID:34767868; PMID:36527706 |
| GO:0051899 | Membrane depolarization | Increases phenotype | PMID:36527706; PMID:37342552 |
| GO:0055065 | Metal ion homeostasis | Decreases phenotype | PMID:19847775 |
| GO:0055069 | Zinc ion homeostasis | Decreases phenotype | PMID:21328412 |
| GO:0055070 | Copper ion homeostasis | Affects phenotype | PMID:37022104 |
| GO:0055071 | Manganese ion homeostasis | Affects phenotype | PMID:37022104 |
| GO:0055072 | Iron ion homeostasis | Affects phenotype | PMID:34558789; PMID:37022104 |
| GO:0055073 | Cadmium ion homeostasis | Affects phenotype | PMID:37022104 |
| GO:0055074 | Calcium ion homeostasis | Affects phenotype | PMID:23497059; PMID:23741317; PMID:32522522; PMID:37148155 |
| GO:0055088 | Lipid homeostasis | Affects phenotype | PMID:30529385 |
| GO:0055089 | Fatty acid homeostasis | Affects phenotype | PMID:30529385; PMID:32007690 |
| GO:0060047 | Heart contraction | Affects phenotype | PMID:23902534 |
| GO:0060079 | Excitatory postsynaptic potential | Decreases phenotype | PMID:8884763 |
| GO:0060135 | Maternal process involved in female pregnancy | Affects phenotype | PMID:38759447 |
| GO:0060218 | Hematopoietic stem cell differentiation | Decreases phenotype | PMID:29939372 |
| GO:0060326 | Cell chemotaxis | Affects phenotype | PMID:31319114; PMID:33188856; PMID:33422613; PMID:33559965; PMID:34488496; PMID:34687772 |
| GO:0060348 | Bone development | Decreases phenotype | PMID:31793751 |
| GO:0060419 | Heart growth | Affects phenotype | PMID:35770551 |
| GO:0060437 | Lung growth | Affects phenotype | PMID:35770551 |
| GO:0060444 | Branching involved in mammary gland duct morphogenesis | Decreases phenotype | PMID:29741670 |
| GO:0060612 | Adipose tissue development | Increases phenotype | PMID:30629257 |
| GO:0060674 | Placenta blood vessel development | Decreases phenotype | PMID:35384129; PMID:37941438 |
| GO:0060711 | Labyrinthine layer development | Increases phenotype | PMID:35770551 |
| GO:0060718 | Chorionic trophoblast cell differentiation | Decreases phenotype | PMID:36370079 |
| GO:0060723 | Regulation of cell proliferation involved in embryonic placenta development | Affects phenotype | PMID:29373603 |
| GO:0061007 | Hepaticobiliary system process | Affects phenotype | PMID:25424620 |
| GO:0061370 | Testosterone biosynthetic process | Decreases phenotype | PMID:29527696; PMID:29527696; PMID:31654709; PMID:36356678; PMID:29527696; PMID:36356678; PMID:31654709; PMID:32781062; PMID:33372294; PMID:33404196; PMID:35236366; PMID:35870590; PMID:36356678 |
| GO:0061739 | Protein lipidation involved in autophagosome assembly | Increases phenotype | PMID:34673407 |
| GO:0061909 | Autophagosome-lysosome fusion | Affects phenotype | PMID:31862506; PMID:34481905; PMID:34695510 |
| GO:0070265 | Necrotic cell death | Increases phenotype | PMID:23636881; PMID:28949029; PMID:33372294; PMID:35934034; PMID:36868496 |
| GO:0070266 | Necroptotic process | Increases phenotype | PMID:37357614 |
| GO:0070269 | Pyroptosis | Increases phenotype | PMID:37300869 |
| GO:0070328 | Triglyceride homeostasis | Affects phenotype | PMID:26187450; PMID:33259630 |
| GO:0070341 | Fat cell proliferation | Decreases phenotype | PMID:38712533 |
| GO:0070374 | Positive regulation of erk1 and erk2 cascade | Increases phenotype | PMID:24824807; PMID:25343777 |
| GO:0070994 | Detection of oxidative stress | Increases phenotype | PMID:16507456; PMID:24936443; PMID:23193971; PMID:23193971; PMID:32347499; PMID:23543441; PMID:26089033; PMID:28433638; PMID:29527696; PMID:29527696; PMID:38712533; PMID:32347499; PMID:32781062; PMID:34767868; PMID:34816377; PMID:34875320; PMID:34998821; PMID:35384154; PMID:35870590; PMID:36527706; PMID:36918407; PMID:37022104; PMID:37300854; PMID:37357614; PMID:38238535; PMID:38289529; PMID:38712533; PMID:39197519; PMID:39725363 |
| GO:0070997 | Neuron death | Increases phenotype | PMID:25461191 |
| GO:0071276 | Cellular response to cadmium ion | Increases phenotype | PMID:25294218; PMID:8108390 |
| GO:0071461 | Cellular response to redox state | Increases phenotype | PMID:31756223 |
| GO:0071480 | Cellular response to gamma radiation | Affects phenotype | PMID:31769258 |
| GO:0072520 | Seminiferous tubule development | Affects phenotype | PMID:35236366 |
| GO:0072593 | Reactive oxygen species metabolic process | Increases phenotype | PMID:15055539; PMID:15055539; PMID:33372294; PMID:20090884; PMID:23339468; PMID:23577223; PMID:23741317; PMID:24952260; PMID:28035397; PMID:29993192; PMID:30717178; PMID:31860779; PMID:32058163; PMID:32142837; PMID:32917723; PMID:33031904; PMID:33372294; PMID:33497711; PMID:33559965; PMID:34510229; PMID:34558789; PMID:34558789; PMID:34767868; PMID:34687772; PMID:34695510; PMID:34767868; PMID:35100813; PMID:36602393; PMID:36602393; PMID:37300854; PMID:36868496; PMID:36918407; PMID:37300854; PMID:37300869; PMID:37342552; PMID:38001299; PMID:38896780; PMID:38944328; PMID:39025289; PMID:8123758 |
| GO:0072674 | Multinuclear osteoclast differentiation | Increases phenotype | PMID:38896780 |
| GO:0072677 | Eosinophil migration | Increases phenotype | PMID:39396604 |
| GO:0080009 | Mrna methylation | Decreases phenotype | PMID:37236586; PMID:39725363 |
| GO:0080020 | Regulation of coenzyme a biosynthetic process | Increases phenotype | PMID:30529385 |
| GO:0080182 | Histone h3-k4 trimethylation | Increases phenotype | PMID:25673502 |
| GO:0086001 | Cardiac muscle cell action potential | Affects phenotype | PMID:29993192 |
| GO:0086004 | Regulation of cardiac muscle cell contraction | Affects phenotype | PMID:29982767 |
| GO:0090024 | Negative regulation of neutrophil chemotaxis | Increases phenotype | PMID:28666365 |
| GO:0090207 | Regulation of triglyceride metabolic process | Affects phenotype | PMID:26187450 |
| GO:0090303 | Positive regulation of wound healing | Increases phenotype | PMID:39032683 |
| GO:0090557 | Establishment of endothelial intestinal barrier | Decreases phenotype | PMID:35934034 |
| GO:0097169 | Aim2 inflammasome complex | Affects phenotype | PMID:31463135 |
| GO:0097189 | Apoptotic body | Increases phenotype | PMID:33652105 |
| GO:0097205 | Renal filtration | Affects phenotype | PMID:25424620 |
| GO:0097212 | Lysosomal membrane organization | Affects phenotype | PMID:34695510 |
| GO:0097213 | Regulation of lysosomal membrane permeability | Affects phenotype | PMID:34695510 |
| GO:0097298 | Regulation of nucleus size | Affects phenotype | PMID:38712533 |
| GO:0097502 | Mannosylation | Affects phenotype | PMID:3667605 |
| GO:0097621 | Monoamine oxidase activity | Increases phenotype | PMID:29170048 |
| GO:0097707 | Ferroptosis | Increases phenotype | PMID:34558789 |
| GO:0097722 | Sperm motility | Decreases phenotype | PMID:29527696; PMID:32781062; PMID:34791780; PMID:35236366; PMID:35236366; PMID:38944328; PMID:35870590; PMID:37506864; PMID:38944328 |
| GO:0097746 | Blood vessel diameter maintenance | Affects phenotype | PMID:29685964 |
| GO:0098659 | Inorganic cation import across plasma membrane | Increases phenotype | PMID:27114535 |
| GO:0098868 | Bone growth | Decreases phenotype | PMID:38896780 |
| GO:0110081 | Negative regulation of placenta blood vessel development | Increases phenotype | PMID:29373603 |
| GO:0110090 | Positive regulation of hippocampal neuron apoptotic process | Increases phenotype | PMID:31271426 |
| GO:0120193 | Tight junction organization | Decreases phenotype | PMID:31390532 |
| GO:0140042 | Lipid droplet formation | Increases phenotype | PMID:36602393; PMID:36918407; PMID:37236586; PMID:39778647 |
| GO:0150078 | Positive regulation of neuroinflammatory response | Increases phenotype | PMID:38595292 |
| GO:0150104 | Transport across blood-brain barrier | Affects phenotype | PMID:36641952 |
| GO:1900227 | Positive regulation of nlrp3 inflammasome complex assembly | Affects phenotype | PMID:31463135 |
| GO:1900409 | Positive regulation of cellular response to oxidative stress | Increases phenotype | PMID:29170048; PMID:31078004 |
| GO:1900745 | Positive regulation of p38mapk cascade | Increases phenotype | PMID:24824807 |
| GO:1901142 | Insulin metabolic process | Affects phenotype | PMID:25867198 |
| GO:1901216 | Positive regulation of neuron death | Increases phenotype | PMID:24824807 |
| GO:1901318 | Negative regulation of flagellated sperm motility | Affects phenotype | PMID:32976933 |
| GO:1901386 | Negative regulation of voltage-gated calcium channel activity | Increases phenotype | PMID:27114535 |
| GO:1901670 | Negative regulation of superoxide dismutase activity | Increases phenotype | PMID:31756223; PMID:38595292 |
| GO:1901671 | Positive regulation of superoxide dismutase activity | Increases phenotype | PMID:32976933 |
| GO:1902071 | Regulation of hypoxia-inducible factor-1alpha signaling pathway | Affects phenotype | PMID:29408318 |
| GO:1902237 | Positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway | Increases phenotype | PMID:37261864 |
| GO:1902552 | Negative regulation of catalase activity | Increases phenotype | PMID:31756223; PMID:37244046 |
| GO:1902600 | Proton transmembrane transport | Affects phenotype | PMID:33038468 |
| GO:1902882 | Regulation of response to oxidative stress | Affects phenotype | PMID:23479318 |
| GO:1903047 | Mitotic cell cycle process | Affects phenotype | PMID:28035397; PMID:31468104 |
| GO:1903283 | Negative regulation of glutathione peroxidase activity | Increases phenotype | PMID:37244046 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Increases phenotype | PMID:23548128; PMID:25464205; PMID:26514923; PMID:27071802; PMID:29111403; PMID:30359721; PMID:30796935 |
| GO:1903428 | Positive regulation of reactive oxygen species biosynthetic process | Increases phenotype | PMID:27687512; PMID:29408318; PMID:37403423; PMID:38595292; PMID:39191366 |
| GO:1903561 | Extracellular vesicle | Increases phenotype | PMID:34044057 |
| GO:1903597 | Negative regulation of gap junction assembly | Increases phenotype | PMID:26165643 |
| GO:1903703 | Enterocyte differentiation | Affects phenotype | PMID:38563870 |
| GO:1903787 | Negative regulation of glutathione biosynthetic process | Increases phenotype | PMID:38595292 |
| GO:1904141 | Positive regulation of microglial cell migration | Increases phenotype | PMID:38595292 |
| GO:1904145 | Negative regulation of meiotic cell cycle process involved in oocyte maturation | Increases phenotype | PMID:29684212 |
| GO:1904659 | Glucose transmembrane transport | Increases phenotype | PMID:39427783 |
| GO:1905037 | Autophagosome organization | Increases phenotype | PMID:34695510 |
| GO:1905146 | Lysosomal protein catabolic process | Decreases phenotype | PMID:34695510 |
| GO:1905220 | Negative regulation of platelet formation | Increases phenotype | PMID:35134237 |
| GO:1905517 | Macrophage migration | Increases phenotype | PMID:39396604 |
| GO:1905603 | Regulation of blood-brain barrier permeability | Decreases phenotype | PMID:20829427 |
| GO:1905898 | Positive regulation of response to endoplasmic reticulum stress | Increases phenotype | PMID:37261864 |
| GO:1990266 | Neutrophil migration | Increases phenotype | PMID:39396604 |
| GO:1990349 | Gap junction-mediated intercellular transport | Decreases phenotype | PMID:26165643 |
| GO:2000052 | Positive regulation of non-canonical wnt signaling pathway | Affects phenotype | PMID:29939372 |
| GO:2000390 | Negative regulation of neutrophil extravasation | Increases phenotype | PMID:28666365 |
| GO:2000726 | Negative regulation of cardiac muscle cell differentiation | Increases phenotype | PMID:36321828 |
| GO:2000872 | Positive regulation of progesterone secretion | Decreases phenotype | PMID:25981801 |
| GO:2001057 | Reactive nitrogen species metabolic process | Affects phenotype | PMID:31639282 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.